The effects of magnesium sulfate on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats. 2004

Mehmet Kaya, and Sefa Gulturk, and Imdat Elmas, and Rivaze Kalayci, and Nadir Arican, and Zuhal Celebi Kocyildiz, and Mutlu Kucuk, and Hatice Yorulmaz, and Ahmet Sivas
Department of Physiology, Istanbul Faculty of Medicine, Istanbul University, Capa-34 390 Istanbul, Turkey. mehkaya@istanbul.edu.tr

The study was performed to evaluate whether magnesium sulfate could alter the degree of disruption of the blood-brain barrier (BBB) caused by hyperosmotic mannitol. Wistar adult female rats were infused with 25% mannitol into the left internal carotid artery. Each animal received intraperitoneally a 300 mg/kg loading dose of magnesium sulfate, dissolved in 0.9% saline, followed by a further 100 mg/kg dose. In the other group, intracarotid infusion of magnesium sulfate was performed at a dose of 150 mg/kg 10 min before mannitol administration. Evans blue (EB) dye was used as a marker of BBB disruption. The measured serum glucose and magnesium levels increased after mannitol and/or magnesium administration when compared with their initial values before treatment (P < 0.01). Water content of the left hemisphere was significantly increased by hyperosmotic mannitol (P < 0.01). The increased water content in the mannitol-perfused hemisphere was significantly decreased by magnesium treatment (P < 0.05). The content of EB dye in the mannitol-perfused hemisphere markedly increased when compared with the right hemisphere of the same brain (P < 0.01). The EB dye content in the mannitol-perfused hemisphere following both intraperitoneal and intraarterial administration of magnesium decreased when compared with mannitol alone (P < 0.01). We conclude that although magnesium sulfate administration by both intracarotid arterial and intraperitoneal routes attenuates BBB disruption caused by hyperosmolar mannitol, particularly intraperitoneal route of magnesium sulfate administration may provide a useful strategy to limit the transient osmotic opening of the BBB.

UI MeSH Term Description Entries
D007261 Infusions, Intra-Arterial Regional infusion of drugs via an arterial catheter. Often a pump is used to impel the drug through the catheter. Used in therapy of cancer, upper gastrointestinal hemorrhage, infection, and peripheral vascular disease. Infusions, Regional Arterial,Infusions, Intra Arterial,Infusions, Intraarterial,Arterial Infusion, Intra,Arterial Infusion, Regional,Arterial Infusions, Intra,Arterial Infusions, Regional,Infusion, Intra Arterial,Infusion, Intra-Arterial,Infusion, Intraarterial,Infusion, Regional Arterial,Intra Arterial Infusion,Intra Arterial Infusions,Intra-Arterial Infusion,Intra-Arterial Infusions,Intraarterial Infusion,Intraarterial Infusions,Regional Arterial Infusion,Regional Arterial Infusions
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D008278 Magnesium Sulfate A small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potentials in myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. (From AMA Drug Evaluations Annual, 1992, p1083) Magnesium Sulfate, Heptahydrate,Heptahydrate Magnesium Sulfate,Sulfate, Magnesium
D008353 Mannitol A diuretic and renal diagnostic aid related to sorbitol. It has little significant energy value as it is largely eliminated from the body before any metabolism can take place. It can be used to treat oliguria associated with kidney failure or other manifestations of inadequate renal function and has been used for determination of glomerular filtration rate. Mannitol is also commonly used as a research tool in cell biological studies, usually to control osmolarity. (L)-Mannitol,Osmitrol,Osmofundin
D009994 Osmolar Concentration The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent. Ionic Strength,Osmolality,Osmolarity,Concentration, Osmolar,Concentrations, Osmolar,Ionic Strengths,Osmolalities,Osmolar Concentrations,Osmolarities,Strength, Ionic,Strengths, Ionic
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D001812 Blood-Brain Barrier Specialized non-fenestrated tightly-joined ENDOTHELIAL CELLS with TIGHT JUNCTIONS that form a transport barrier for certain substances between the cerebral capillaries and the BRAIN tissue. Brain-Blood Barrier,Hemato-Encephalic Barrier,Barrier, Blood-Brain,Barrier, Brain-Blood,Barrier, Hemato-Encephalic,Barriers, Blood-Brain,Barriers, Brain-Blood,Barriers, Hemato-Encephalic,Blood Brain Barrier,Blood-Brain Barriers,Brain Blood Barrier,Brain-Blood Barriers,Hemato Encephalic Barrier,Hemato-Encephalic Barriers
D001929 Brain Edema Increased intracellular or extracellular fluid in brain tissue. Cytotoxic brain edema (swelling due to increased intracellular fluid) is indicative of a disturbance in cell metabolism, and is commonly associated with hypoxic or ischemic injuries (see HYPOXIA, BRAIN). An increase in extracellular fluid may be caused by increased brain capillary permeability (vasogenic edema), an osmotic gradient, local blockages in interstitial fluid pathways, or by obstruction of CSF flow (e.g., obstructive HYDROCEPHALUS). (From Childs Nerv Syst 1992 Sep; 8(6):301-6) Brain Swelling,Cerebral Edema,Cytotoxic Brain Edema,Intracranial Edema,Vasogenic Cerebral Edema,Cerebral Edema, Cytotoxic,Cerebral Edema, Vasogenic,Cytotoxic Cerebral Edema,Vasogenic Brain Edema,Brain Edema, Cytotoxic,Brain Edema, Vasogenic,Brain Swellings,Cerebral Edemas, Vasogenic,Edema, Brain,Edema, Cerebral,Edema, Cytotoxic Brain,Edema, Cytotoxic Cerebral,Edema, Intracranial,Edema, Vasogenic Brain,Edema, Vasogenic Cerebral,Swelling, Brain
D002339 Carotid Arteries Either of the two principal arteries on both sides of the neck that supply blood to the head and neck; each divides into two branches, the internal carotid artery and the external carotid artery. Arteries, Carotid,Artery, Carotid,Carotid Artery
D004234 Diuretics, Osmotic Compounds that increase urine volume by increasing the amount of osmotically active solute in the urine. Osmotic diuretics also increase the osmolarity of plasma. Osmotic Diuretic,Osmotic Diuretics,Diuretic, Osmotic

Related Publications

Mehmet Kaya, and Sefa Gulturk, and Imdat Elmas, and Rivaze Kalayci, and Nadir Arican, and Zuhal Celebi Kocyildiz, and Mutlu Kucuk, and Hatice Yorulmaz, and Ahmet Sivas
June 1998, Anesthesia and analgesia,
Mehmet Kaya, and Sefa Gulturk, and Imdat Elmas, and Rivaze Kalayci, and Nadir Arican, and Zuhal Celebi Kocyildiz, and Mutlu Kucuk, and Hatice Yorulmaz, and Ahmet Sivas
March 2000, Anesthesia and analgesia,
Mehmet Kaya, and Sefa Gulturk, and Imdat Elmas, and Rivaze Kalayci, and Nadir Arican, and Zuhal Celebi Kocyildiz, and Mutlu Kucuk, and Hatice Yorulmaz, and Ahmet Sivas
February 1997, Anesthesia and analgesia,
Mehmet Kaya, and Sefa Gulturk, and Imdat Elmas, and Rivaze Kalayci, and Nadir Arican, and Zuhal Celebi Kocyildiz, and Mutlu Kucuk, and Hatice Yorulmaz, and Ahmet Sivas
August 1996, Anesthesia and analgesia,
Mehmet Kaya, and Sefa Gulturk, and Imdat Elmas, and Rivaze Kalayci, and Nadir Arican, and Zuhal Celebi Kocyildiz, and Mutlu Kucuk, and Hatice Yorulmaz, and Ahmet Sivas
October 2007, Journal of neurosurgical anesthesiology,
Mehmet Kaya, and Sefa Gulturk, and Imdat Elmas, and Rivaze Kalayci, and Nadir Arican, and Zuhal Celebi Kocyildiz, and Mutlu Kucuk, and Hatice Yorulmaz, and Ahmet Sivas
May 2021, Proceedings of the National Academy of Sciences of the United States of America,
Mehmet Kaya, and Sefa Gulturk, and Imdat Elmas, and Rivaze Kalayci, and Nadir Arican, and Zuhal Celebi Kocyildiz, and Mutlu Kucuk, and Hatice Yorulmaz, and Ahmet Sivas
June 1987, Brain research,
Mehmet Kaya, and Sefa Gulturk, and Imdat Elmas, and Rivaze Kalayci, and Nadir Arican, and Zuhal Celebi Kocyildiz, and Mutlu Kucuk, and Hatice Yorulmaz, and Ahmet Sivas
January 1982, Investigative radiology,
Mehmet Kaya, and Sefa Gulturk, and Imdat Elmas, and Rivaze Kalayci, and Nadir Arican, and Zuhal Celebi Kocyildiz, and Mutlu Kucuk, and Hatice Yorulmaz, and Ahmet Sivas
January 2008, Pharmacology,
Mehmet Kaya, and Sefa Gulturk, and Imdat Elmas, and Rivaze Kalayci, and Nadir Arican, and Zuhal Celebi Kocyildiz, and Mutlu Kucuk, and Hatice Yorulmaz, and Ahmet Sivas
July 2000, Acta pharmacologica Sinica,
Copied contents to your clipboard!